Gilead Sciences Inc articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/11/19 03:17
2014/11/19 03:17
4d
FOSTER CITY, Kalifornien (USA)--(BUSINESS WIRE)--Das Unternehmen Gilead Sciences, Inc. (NASDAQ: GILD), hat heute bekannt gegeben, dass es von der Europäischen Kommission die Zulassung für Harvoni®...
2014/11/19 03:17
2014/11/19 03:17
Latest videos
2014/11/19 02:17
2014/11/19 02:17
4d
Europese Commissie verleent vergunning voor het in de handel brengen voor Gilead’s Harvoni®▼ (Ledipasvir/Sofosbuvir), het eerste enkel-tabletregime voor de behandeling van patiënten met chronische...
2014/11/18 21:27
2014/11/18 21:27
4d
Nov. 18 (Bloomberg) -- It costs drugmakers $2.56 billion to bring a new medicine to market, on average, more than double the price of 11 years ago, according to a study released today. The higher...
2014/11/18 18:49
2014/11/18 18:49
4d
This is the second installment in a four-part series. LOS ANGELES (MarketWatch) -- Look around the health-care world, and the almighty dollar can rear its head just about anywhere. It’s often seen...
2014/11/17 12:13
2014/11/17 12:13
5d
Twenty-five years after scientists first identified the hepatitis C virus, doctors are declaring victory over an infection that afflicts more than 3 million Americans and kills more of them than...
2014/11/14 23:48
2014/11/14 23:48
8d
Janus Capital Group, Inc. (JNS), formerly one of the largest asset management firms in the world and now hoping for resurgence with the signing of PIMCO founder Bill Gross, sells multiple mutual funds...
2014/11/13 09:17
2014/11/13 09:17
9d
FOSTER CITY, Californie--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ : GILD) a annoncé aujourd’hui la détermination du prix de billets de premier rang non garantis d’un montant total en principal...
2014/11/12 23:18
2014/11/12 23:18
10d
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) today announced the pricing of senior unsecured notes in an aggregate principal amount of $4 billion, in an underwritten,...
2014/11/12 05:27
2014/11/12 05:27
11d
Hepatitis C drug of Gilead Sciences gets positive results BOSTON - Gilead Sciences, Inc., US biotechnology company, Tuesday announced a high success rate for its new Harvoni drug for hepatitis C...
2014/11/12 00:17
2014/11/12 00:17
11d
Gilead comunica i dati derivati dagli studi condotti su Harvoni per il trattamento di pazienti con infezione cronica da virus dell’epatite C con malattia epatica avanzata e pazienti che non hanno...
2014/11/10 17:49
2014/11/10 17:49
12d
Companies in the S&P 500 Index, despite concerns of a slowdown in global economic growth, are increasing revenue at twice the pace of the U.S. economy. As this is the first month without stimulus...
2014/11/10 17:49
2014/11/10 17:49
12d
LOS ANGELES (MarketWatch) — Two drug makers on vastly different paths both found themselves in negative territory Monday, as Dow component Merck & Co. Inc. slipped on a disappointing drug trial result...
2014/11/10 15:21
2014/11/10 15:21
12d
Bloomberg News Merck & Co. won't move forward with an ultra-short hepatitis C regimen that attempted to cut treatment durations in half by combining two of its drugs with another from Gilead Sciences...
2014/11/07 09:06
2014/11/07 09:06
15d
Next to Alice Gorman’s bed is a small suitcase packed with clothes and a fully charged mobile phone she carries wherever she goes. The news she’s waiting for: a donated liver that matches her blood...
2014/11/07 00:17
2014/11/07 00:17
16d
FOSTER CITY, Californië (VS)--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) heeft vandaag bekendgemaakt dat het bedrijf een nieuwe geneesmiddelaanvraag (New Drug Application, NDA) heeft...
2014/10/31 17:12
2014/10/31 17:12
22d
Since Shire deal collapsed, AbbVie's probably done with mega mergers Health Care Headlines (Bloomberg) — AbbVie Inc. probably won't make another $50 billion-plus deal after walking away from a...
2014/10/31 02:17
2014/10/31 02:17
23d
FOSTER CITY, Californië (VS)--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) heeft vandaag haar bedrijfsresultaten bekendgemaakt voor het kwartaal eindigend op 30 september 2014. De totale...
2014/10/30 09:09
2014/10/30 09:09
23d
U.S. stocks declined Wednesday after the Federal Reserve confirmed it will end its asset-purchase program, indicating the U.S. economy is on a stable growth path. Facebook Inc. fell after forecasts...
2014/10/30 01:20
2014/10/30 01:20
24d
Socialized health care in the United States comes by incrementalism, as if on little cat feet. Obamacare and its exchanges preserve the illusion of a free market for insurance coverage, but we’re...
2014/10/29 12:16
2014/10/29 12:16
24d
U.S. stock-index futures were little changed, after equities rallied to a one-month high, as Facebook Inc. tumbled and as investors awaited the Federal Reserve’s monetary-policy decision. Facebook...
2014/11/19 03:17
2014/11/19 03:17
Latest from Twitter